tiprankstipranks
Advertisement
Advertisement

NVS Stock Latest News

3 Stocks Under $10 With Over 100% Upside, According to Analysts
Market News3 Stocks Under $10 With Over 100% Upside, According to Analysts
3d ago
LLY
NVS
Novartis’ iptacopan granted FDA orphan designation
PremiumThe Fly
Novartis’ iptacopan granted FDA orphan designation
6d ago
NVS
3 Dividend ETFs Crushing the S&P 500 in 2026
PremiumMarket News
3 Dividend ETFs Crushing the S&P 500 in 2026
8d ago
VZ
CVX
SCHD vs. VYMI vs. VIG: Which Is the Best Dividend ETF for Passive Income Investors?
PremiumMarket News
SCHD vs. VYMI vs. VIG: Which Is the Best Dividend ETF for Passive Income Investors?
13d ago
HD
ABT
3 Vanguard Dividend ETFs to Boost Passive Income
PremiumMarket News
3 Vanguard Dividend ETFs to Boost Passive Income
15d ago
NVS
HSBC
Morgan Stanley’s Graham Parry Reiterates Buy on Novartis, Citing Pelacarsen Upside and Above‑Consensus EPS Outlook
PremiumRatingsMorgan Stanley’s Graham Parry Reiterates Buy on Novartis, Citing Pelacarsen Upside and Above‑Consensus EPS Outlook
18d ago
NVS
Amgen price target raised to $351 from $333 at Morgan Stanley
Premium
The Fly
Amgen price target raised to $351 from $333 at Morgan Stanley
20d ago
NVS
AMGN
Novartis says FDA approves Pluvicto for PSMA+ metastatic prostate cancer
Premium
The Fly
Novartis says FDA approves Pluvicto for PSMA+ metastatic prostate cancer
25d ago
NVS
SCHD vs. VYMI: Which Dividend ETF Comes Out on Top?
PremiumMarket News
SCHD vs. VYMI: Which Dividend ETF Comes Out on Top?
26d ago
ABT
MRK
Novartis: Solid Fundamentals but Balanced Risk-Reward Justify Hold Rating
PremiumRatings
Novartis: Solid Fundamentals but Balanced Risk-Reward Justify Hold Rating
29d ago
NVS
3 Best Vanguard ETFs to Boost Your Dividend Income
PremiumMarket News
3 Best Vanguard ETFs to Boost Your Dividend Income
29d ago
RY
NVS
Novartis: Balanced Upside Potential and Execution Risks Lead Analyst to Maintain Hold Rating Ahead of Key Phase III Readouts
PremiumRatings
Novartis: Balanced Upside Potential and Execution Risks Lead Analyst to Maintain Hold Rating Ahead of Key Phase III Readouts
29d ago
NVS
Nuvectis’ NXP100 Just Achieved the First Marketing Approval Ever for a Once-Daily Oral Factor B Inhibitor
PremiumTipRanks NewswireNuvectis’ NXP100 Just Achieved the First Marketing Approval Ever for a Once-Daily Oral Factor B Inhibitor
1M ago
NVS
CRNX
VYMI vs. SCHD: Which Is the Best Dividend ETF for Passive Income?
Premium
Market News
VYMI vs. SCHD: Which Is the Best Dividend ETF for Passive Income?
1M ago
ABT
MRK
Novartis price target raised to CHF 142 from CHF 132 at Citi
Premium
The Fly
Novartis price target raised to CHF 142 from CHF 132 at Citi
1M ago
NVS
Trump Trade: U.S. to impose 100% tariff on imported generic drugs
PremiumThe Fly
Trump Trade: U.S. to impose 100% tariff on imported generic drugs
1M ago
XE
AAL
Novartis: Sell Rating Maintained as Timing-Driven Upside Keeps Risk‑Reward Unfavorable; $111 Price Target Reaffirmed
PremiumRatings
Novartis: Sell Rating Maintained as Timing-Driven Upside Keeps Risk‑Reward Unfavorable; $111 Price Target Reaffirmed
1M ago
NVS
Novartis: Buy Rating Reiterated on Q2 Beat, Strong Growth Brands and Pipeline Upside; Price Target Maintained at $140
PremiumRatings
Novartis: Buy Rating Reiterated on Q2 Beat, Strong Growth Brands and Pipeline Upside; Price Target Maintained at $140
1M ago
NVS
Novartis Earnings Call Highlights Growth Amid Headwinds
PremiumCompany Announcements
Novartis Earnings Call Highlights Growth Amid Headwinds
1M ago
NVS
Trump to set 100% tariff on generic drugs brought into U.S. starting in 2028
PremiumThe FlyTrump to set 100% tariff on generic drugs brought into U.S. starting in 2028
1M ago
AZN
BMY
Midday Fly By: GM, 3M, Hasbro all post beat and raise reports
Premium
The Fly
Midday Fly By: GM, 3M, Hasbro all post beat and raise reports
1M ago
GM
RL
Morning Movers: Equifax sinks following second quarter earnings
Premium
The Fly
Morning Movers: Equifax sinks following second quarter earnings
1M ago
GM
DHI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >